TherapeuticsMD TXMD
NASDAQ TXMD
$1.87 -0.03 (-1.68%)
As of: Oct 22, 2026 · 12:03 PM EDT

TherapeuticsMD (TXMD) Liabilities from Discontinued Operations (2022 - 2024)

Updated

TherapeuticsMD (TXMD) recorded Liabilities from Discontinued Operations of $6 million in Q2 2024, down 5.0% from the prior quarter.

Analysis

TherapeuticsMD (TXMD) Liabilities from Discontinued Operations (2022 - 2024) Analysis & Trends

At the end of FY2023, TherapeuticsMD reported Liabilities from Discontinued Operations of $6.53 million, down 11.4% from FY2022.

  • Across earlier years, Liabilities from Discontinued Operations came in at $7.37 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.57 Bn 1,139.16 Bn 19.71 Bn
2 Johnson & Johnson 641.68 Bn 560.21 Bn 17.26 Bn
3 AbbVie 502.16 Bn 475.27 Bn 12.70 Bn
4 Merck 375.54 Bn 329.92 Bn 12.21 Bn
5 Novartis Ag 302.70 Bn 266.69 Bn 11.24 Bn
6 Astrazeneca 268.54 Bn 242.22 Bn 12.86 Bn
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn
8 Gilead Sciences 193.36 Bn 167.56 Bn 6.22 Bn
9 Pfizer 172.54 Bn 119.18 Bn 10.94 Bn
10 TherapeuticsMD 21.62 Mn 21.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 6.00 Mn
Mar 31, 2024 6.32 Mn
Dec 31, 2023 6.53 Mn
Dec 31, 2022 7.37 Mn
API Access

TherapeuticsMD Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=TXMD&period=max&api_key=YOUR_API_KEY